AstraZeneca Collaborates with Gendius to Provide Diabetes Management Support for Patients in the GCC

 AstraZeneca Collaborates with Gendius to Provide Diabetes Management Support for Patients in the GCC

Shots:

  • The collaboration is built on Gendius’ diabetes management platform, Intellin, which has 200,000+ downloads worldwide. With the partnership, AstraZeneca allows HCPs across the Gulf region to use Gendius’ Intellin to augment diabetes management for reducing the incidence of complications
  • The partnership is being implemented within the framework of AstraZeneca’s Emerging Markets Health Innovation Hubs initiative to bring digital, R&D and commercial industries within emerging countries for improving patients’ outcomes. Intellin is compatible with 150+ apps and connected health devices, ranging from Fitbit and Garmin devices, to more specialist blood glucose monitors and blood pressure cuffs
  • As a result of collaboration, HealthGATE platform and app to support diabetic patient care in the GCC, will be launched later this year. The HealthGATE app will work as a gateway between HCPs and patients, enabling collaboration for personalized care and the use of AI for better disease management

Click here, Click here to read full press release/ article | Ref: Gendius | Image: Gendius

Shiwani Sharma

Shiwani Sharma is a Senior Editor at PharmaShots. She has in-depth knowledge of lifesciences industry including pharma and biotech sectors. She also covers news in field of Digital Health, Medtech and regulatory approvals from the US FDA, EU, and other global regulatory bodies in the industry. Additionally, she also writes Whitepapers, analysis reports, blogs on pharma and biotech industry. She is graduate in Biotechnology. She can be contacted on shiwani@pharmashots.com

Related post